These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 7627336
21. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion. Allolio B, Winkelmann W, Hipp FX, Kaulen D, Mies R. J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297 [Abstract] [Full Text] [Related]
22. Pituitary macroadenoma in Addison's disease. Akçay G, Aral F, Ozbey N, Azezli A, Orhan Y, Sencer E, Molvalilar S. J Int Med Res; 1996 Jul; 24(2):221-7. PubMed ID: 8737233 [Abstract] [Full Text] [Related]
23. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells? Loli P, Boccardi E, Branca V, Bramerio M, Barberis M, Losa M, Terreni MT, Lodrini S, Pollo B, Vignati F. Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339 [Abstract] [Full Text] [Related]
24. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Buurman H, Saeger W. Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024 [Abstract] [Full Text] [Related]
25. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA. Yen TC, King KL, Yang AH, Liu RS, Yeh SH. J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007 [Abstract] [Full Text] [Related]
26. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings. Tamanini JVG, Dal Fabbro M, de Freitas LLL, Vassallo J, de Souza Queiroz L, Rogerio F. Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373 [Abstract] [Full Text] [Related]
27. In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. Ferone D, Pivonello R, Lastoria S, Faggiano A, Del Basso de Caro ML, Cappabianca P, Lombardi G, Colao A. Clin Endocrinol (Oxf); 2001 Apr; 54(4):469-77. PubMed ID: 11318782 [Abstract] [Full Text] [Related]
28. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma. Kong YG, Ren ZY, Su CB, Wang RZ, Ma WB, Lian W. Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648 [Abstract] [Full Text] [Related]
29. Evaluation of a Novel General Pituitary Hormone Score to Evaluate the Function of the Residual Anterior Pituitary (Adenohypophysis) in Patients Following Surgery for Pituitary Adenoma. Wang S, Ding C, Xiao D, Wu Z, Wei L. Med Sci Monit; 2018 Nov 06; 24():7944-7951. PubMed ID: 30397189 [Abstract] [Full Text] [Related]
30. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment. Teramoto A, Sanno N, Tahara S, Osamura YR. Acta Neuropathol; 2004 Aug 06; 108(2):147-53. PubMed ID: 15185102 [Abstract] [Full Text] [Related]
32. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas. Astaf'eva LI, Kadashev BA, Shishkina LV, Kalinin PL, Fomichev DV, Kutin MA, Aref'eva IA, Dzeranova LK, Sidneva YG, Klochkova IS, Rotin DL. Zh Vopr Neirokhir Im N N Burdenko; 2016 Sep 15; 80(6):24-35. PubMed ID: 28139570 [Abstract] [Full Text] [Related]
33. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC, Chen FW, Hsieh HC. Taiwan Yi Xue Hui Za Zhi; 1989 May 15; 88(5):443-9. PubMed ID: 2507734 [Abstract] [Full Text] [Related]
34. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid. Kobayashi H, Suzuki KH, Sakahara H, Yao ZS, Yokoyama A, Konishi J. Eur J Nucl Med; 1995 Jun 15; 22(6):559-62. PubMed ID: 7556304 [Abstract] [Full Text] [Related]
35. Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal. Keye WR, Chang RJ, Monroe SE, Wilson CB, Jaffe RB. Am J Obstet Gynecol; 1979 Jun 15; 134(4):360-5. PubMed ID: 222148 [Abstract] [Full Text] [Related]
36. 'Silent' somatotropinoma. Pawlikowski M, Kuta J, Fuss-Chmielewska J, Winczyk K. Endokrynol Pol; 2012 Jun 15; 63(2):88-91. PubMed ID: 22538745 [Abstract] [Full Text] [Related]
37. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy. Hirano T, Tomiyoshi K, Zhang YJ, Ishida T, Inoue T, Endo K. Eur J Nucl Med; 1994 Jan 15; 21(1):82-5. PubMed ID: 8088289 [Abstract] [Full Text] [Related]
38. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors. Ishibashi M, Yamaji T, Takaku F, Teramoto A, Fukushima T. J Clin Endocrinol Metab; 1987 Jun 15; 64(6):1187-93. PubMed ID: 2437140 [Abstract] [Full Text] [Related]
39. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA. Hirano T, Otake H, Yoshida I, Endo K. J Nucl Med; 1995 Feb 15; 36(2):202-7. PubMed ID: 7830114 [Abstract] [Full Text] [Related]
40. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas. Shao S, Li X. J Neurosurg Sci; 2013 Sep 15; 57(3):267-75. PubMed ID: 23877272 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]